Lanam SC 200 mg/28.5mg Imexpharm powder treated infections, acute sinusitis, otitis media (12 packs x 0.8g)

Dosage form 12 package box
Specifications Amoxicillin, clavulanic acid

Ingredient

Composition informationContent
Amoxicilin200mg
Clavulanic acid28.5mg

Uses

Indications

Powder mixed with oral fluid SC 200mg/28.5mg is indicated in the treatment of infections caused by drugs that are sensitive to drugs such as:

  • acute sinusitis caused by bacteria.
  • Acute otitis media.
  • Exacection of chronic bronchitis.
  • Pneumonia is suffering from the community.
  • cystitis.
  • Nephritis - Pyelonephritis.
  • Skin infections and subcutaneous organization especially in cellular inflammation, insect bites, serious toothpass abscess leading to cellular inflammation.
  • Bone and joint infections, especially osteomyelitis.

    ATC code: J01CR02.

    Mechanism of operation: Amoxicillin is a semi -synthetic antibiotic belonging to the penicillin group (betalactam antibiotic). Amoxicilin has bactericidal effects that attach to one or more protein of bacterial penicillin (Pbps) to inhibit peptidoglycan biosynthesis, which is a component of bacterial cell walls. Finally, the bacteria decompose by the enzymes to destroy the bacterial cell wall. Amoxicillin is easily destroyed by beta lactamase enzymes and therefore the antibacterial spectrum of the monounsaturated amoxicillin does not include bacteria that produce these enzymes. Clavulanic acid is a beta-lactam, structurally related to penicillin. Clavulanic acid has the ability to inhibit beta lactamase enzymes and therefore, prevent inactivity to amoxicillin. Clavulanic acid monomers do not have clinical antibacterial effects.

    Lanam SC 200 mg/28.5 mg is a combination of amoxicillin and clavulanic acid. This coordination does not change the mechanism of the effect of amoxicillin but has the effect of anti-bactericidal, expanding the effect of amoxicillin against many bacteria that produce beta lactamase previously resistant to Amoxicilin monon treatment, due to clavulanic acid with high affinity and attached to beta-lactamase of bacteria to inhibit.

    Hematology/ pharmacokinetic association: The time of antibiotic concentration is higher than the minimum inhibitory concentration (T> MIC) is the main parameter that shows the effect of amoxicillin.

    Resistance mechanism: The two main mechanisms of resistance bacteria for amoxicillin/ clavulanic acid combination are:

  • Inactive drugs by beta-lactamase are not inhibited by clavulanic acid, including layer B, C, D.
  • transforms penicillin-mounted proteins (Pbps), thus reducing the affection of antibacterial agent at the position.
  • A decrease in bacterial permeability or pumping mechanism can cause or contribute to the resistance of bacteria, especially in Gram -negative bacteria.
  • Antibacterial spectrum of drugs: Sensitive bacteria:

    Aerobic Gram -positive bacteria: Enterococcus Faecalis, Gardnerella £ Vaginalis, Staphylococcus aureus (methicilin sensitive) (2), Staphylococcus spp. negative with coagulase (sensitive to methicilin), Streptococcus 1 Agalactiae, Streptococcus Pneumoniae (3), Streptococcus Pyogenes and Streptococcus spp. Other β hemolysis, Streptococcus Viridans.

    Aerobic Gram -negative bacteria: Capnocytophaga spp.

    Anaerobic bacteria: Bacteroides Fragilis, Fusobacterium nucleatum, Prevotella spp.

    Bacteria may have problems with drug resistance:

  • Aerobic Gram -positive bacteria: Enterococcus Faecium (1).
  • Bacteria that are inherently resistant to drugs: Aerobic Gram -negative bacteria: Acinetobacter sp.
  • Other: Chlamydophila Pneumoniae, Chlamydophila Psittaci, Coxiella Burnetii, Mycoplasma Pneumoniae.
  • (1) Natural intermediate sensitivity has no resistance mechanism.

    (2) All Staphylococcus spp. Methicilin resistance is resistant to amoxicillin/ clavulanic acid combination.

    (3) Combining amoxicillin/ clavulanic acid may not be suitable for treating streptococcus pneumoniae resistance to penicillin.

    (4) has reported on sensitive reduction strains in some countries in the European Union (EU) with a higher frequency of 10%.

    pharmacokinetics

    absorption:

    Amoxicillin and clavulanic acid are completely dissociated in water solution in physiological pH. Both ingredients are well absorbed and quickly after drinking. After drinking, bioavailability of amoxicillin and clavulanic acid is about 70%. The characteristics of two plasma components are the same and the time to reach the peak concentration in the plasma (TMAX) of each component is about 1 hour. The pharmacokinetics results obtained from a study that amoxicillin/ clavulanic acid (875 mg/ 125 mg tablets are used 2 times/ day) are taken while hungry in healthy volunteers presented below:

    Average pharmacokinetic parameters (± sd)

    pharmaceutical substance is taken Dosage cmax AUC (0-24 (0-24 hour) T1/2 AMX/CA 875 mg/125 mg 875 11.64 ± 2.78 1.50 (1.0 - 2.5) 53,52 ± 12,31 1,19 ± 0.21

    AMX/CA 875 mg/125 mg 125 2.18 ± 0.99 1.25 (1.0 - 2.0)

    10.16 ± 3.04 0.96 ± 0.12 - Clavulanic acid

    * Middle (interval)

    distribution:

    About 25% Clavulanic acid and 18% amoxicillin associated with plasma proteins. The apparent distribution volume is about 0.3 - 0.4 l/kg for amoxicillin and about 0.2 l/kg for clavulanic acid. After intravenous injection, both amoxicillin and clavulanic acid have been found in the gallbladder, abdominal tissue, skin, fat, muscle tissue, fluid and peritoneal fluid, bile and pus of the wound. Amoxicillin is not much distributed in cerebrospinal fluid.

    Animal studies show that there is no storage of drug metabolites in the body. Like other antibiotics penicillin, amoxicillin can be distributed into breast milk. A very small amount of Clavulanic acid has also been discovered in breast milk. Both amoxicilin and clavulanic acid have passed the placenta fence.

    transformation:

    about 10 - 25% amoxicillin in the starting dose is excreted in urine in the form of peniciloic acid that does not work. Clavulanic acid metabolizes a lot in the human body, excreted into urine, feces and in the form of carbon dioxid in exhaled gas.

    excretion:

    Amoxicillin is excreted mainly through the kidneys, while clavulanic acid is eliminated by the mechanism through both the kidneys and outside the kidneys. Combining amoxicillin/ clavulanic acid has an average selling time for about 1 hour and total clearance of about 25 l/ h in healthy people. Nearly 60 - 70% amoxicillin and 40 - 65% of Clavulanic acid are eliminated in urine in the form of unchanged in the first 6 hours after taking a single tablet with amoxicillin/ clavulanic acid with a content of 250 mg/ 125 mg or 500 mg/ 125 mg.

    Different studies show that about 50 - 85% amoxicillin and 27 - 60% of Clavulanic acid are eliminated through urine for 24 hours. Clavulanic acid is most eliminated in the first 2 hours after taking the drug. Concomitant use with probenecid may slow down amoxicillin, but does not affect the elimination of clavulanic acid through the kidney.

    Age:

    Amoxicillin's sale time in children from 3 months to 2 years old is equivalent to older children and adults. In newborns (including premature babies), in the first week after birth, do not use more than 2 times/day because the emissions through the kidneys have not been fully developed. Because the elderly people have a higher impairment of renal function, it is necessary to be cautious when choosing the dose and monitoring the kidney function throughout the treatment process.

    Sex:

    After drinking amoxicilin/ clavulanic acid in healthy women and men shows that gender does not significantly affect the pharmacokinetics of both amoxicillin and clavulanic acid.

    kidney failure:

    The total serum clearance coefficient of amoxicillin/ clavulanic acid decreases corresponding to the impaired renal function. The decrease in amoxicillin clearance is more pronounced than clavulanic acid, as the ratio of amoxicillin eliminates through the kidneys is higher. Therefore, the dose for patients with renal impairment must prevent excessive accumulation of amoxicillin while maintaining the appropriate clavulanic acid level.

    liver failure:

    Patients with liver failure should be carefully indicated and monitored liver function periodically.

    Before taking Lanam SC 200 mg/28.5mg Imexpharm powder treated infections, acute sinusitis, otitis media (12 packs x 0.8g)

    How to use

    Powder mixed with oral fluid SC 200mg/28.5mg is used by oral: Put the powder into the glass, add a little water (about 5 ml), stir until the powder is completely dispersed and use immediately.

    Time of taking the drug: Take the meal at the beginning of the meal to minimize the possibility of intolerance in the digestive tract.

    Dosage

    The dosage is usually shown according to the content of amoxicillin/clavulanic acid unless it is stated according to the dose of each individual ingredient.

    The choice of the dose of Lanam SC 200mg/28.5mg depends on the following factors:

  • The type of pathogenic bacteria and the ability to be sensitive to antibacterial agent. Consider when necessary.

    For children weighing

    Treatment time should be considered depending on the response of the patient. Some bacterial infections (such as osteomyelitis) require longer treatment time. Do not extend the treatment time more than 14 days without re -assessing the patient's condition.

    Adults and children from 40 kg should use other products with amoxicillin/ macid Clavulanic content more suitable for adults.

    Children weighs

    Recommended dose:

  • 25 mg/3.6 mg/kg/day to 45 mg/6.4 mg/kg/day divided into two oral times. Clavulanic ratio 7/1 with a dose of over 45 mg/6.4 mg/kg/day in children under 2 years old.

    There is no clinical data on the use of amoxicillin/ clavulanic acid in 7/1 ratio for children under 2 months old. Therefore, the proposal for these subjects has not been implemented.

    Elderly:

    There is no need to adjust the dose.

    Patients with renal failure:

  • Patients with creatinine clearance (CrCl) greater than 30 ml/minute: No dose needed.

    Be cautious about dosage when using and periodically check liver function during drug use.

    What to do when overdose?

    overdose:

    Symptoms on the gastrointestinal tract and water balance disorders, electrolytes may be an expression of overdose. Observed the urinary amoxicillin crystal, in some cases, the kidney failure.

    Seism can occur in patients with renal failure or high doses.The crystal of amoxicillin has also been found in the bladder tubes, especially after using high doses through the injection. Therefore, it is necessary to periodically check the status of the bladder tubes.

    How to handle:

    Stop using drugs, treat symptoms on the gastrointestinal tract and monitor water and electrolyte balance.

    It is possible to remove amoxicilin/ clavulanic acid from circulation by hemolysis method.

    What to do when forgetting a dose?

    Use the next dose after at least 4 hours. Do not use double dose to compensate for missed dose.

  • Side Effects

    The most unwanted reaction of the most common drug is diarrhea, nausea and vomiting.

    Common (1/100 ≤ ADR

    Infections and parasites: Candida fungus on the skin mucosa.

    Digestive system: diarrhea, nausea (often occurring when taking the drug in high doses, can take the drug at the beginning of the meal to minimize the effects on the gastrointestinal tract), vomiting.

    Less (1/1,000 ≤ ADR

    Nervous system: dizziness, headache.

    Digestive system: indigestion.

    liver - bile: increase AST and/ or ALT (increase the average AST and/ or ALT has been recorded in patients treated with betalactam antibiotics, however, the meaning of these findings is not known).

    Skin and subcutaneous organization: skin rash, itching, urticaria.

    Rare (1/10,000 ≤ ADR

    Blood and lymphatic system: Restoration of leukemia (including neutropenia) and platelets.

    Skin and subcutaneous organization: Diverse roses.

    Unknown frequency: infection and parasitic infection: superinfection of microorganisms that are not sensitive to drugs.

    Blood and lymphatic system: Healed leukocytes, hemolytic anemia, prolonged bleeding time and prothrombin time.

    The immune system: Neuroscopy, anaphylaxis, serum like serum, hypersensitivity.

    Nervous system: Hypertension with recovery, convulsions, sterile meningitis.

    The digestive system: Antibiotic colitis (including fake colitis and bleeding colitis), black hair growth, tooth color change (changing enamel color that has been reported in children, but very rarely occur. Good oral hygiene can be prevented because this symptom can be removed by brushing teeth).

    Hepatitis: Hepatitis and jaundice (these side effects have been recorded in patients treated with antibiotics of cephalosporin groups and other penicillin groups).

    Skin and subcutaneous organization: Stevens-Johnson syndrome, poisoned skin epidermis, flaking dermatitis, external pustules (AGEP), acidic rash syndrome with acidic hypertension and systemic symptoms (Dress).

    Kidney and urinary: interstitial nephritis, crystal.

    Instructions on how to handle ADR:

    If serious allergic reactions such as angioedema, anaphylaxis, Stevens-Johnson syndrome ... must stop the drug and immediately treat emergency treatment with adrenalin, oxygen breathing, intravenous corticoid therapy and ventilation, including intra-intubation and never treated with drugs containing penicilin or cephalosporin again.

    Management when fake colitis:

    Mild: Stop drugs.

    Heavy: Application of water and electrolytes, using anti -Clostridium antibiotics (metronidazol, vancomycin).

    Notice immediately to the doctor or pharmacist the harmful reactions encountered when using the drug.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Lanam SC 200mg/28.5mg contraindications in the following cases:

  • Patients with amoxicillin, clavulanic acid, other antibiotics belonging to the penicillin group or any component of the drug (see the ingredient section of the formula). Monobactam).

    Be cautious when using

    need to be very careful when taking the drug for patients in the following cases:

    Before starting treatment with Lanam SC 200mg/28.5mg, the patient's allergic history should be carefully investigated with penicillin, cephalosporin or other betalactam drugs.

    Severe hypersensitivity reactions and sometimes fatal (such as anaphylaxis and serious side effects) have been recorded in patients treated with penicillin drugs. These reactions often occur in patients with a history of allergies to penicillin and other allergens. If the allergic reaction occurs, it is necessary to stop using amoxicillin/ clavulanic acid and other treatments for other appropriate treatment.

    During treatment with Lanam SC 200mg/28.5mg, if the bacteria have been identified as sensitive to amoxicillin, it is possible to switch to single amoxicillin.

    This drug is not suitable for treating bacterial infections caused by bacteria that have been resistant to beta-lactam antibiotics under the intermediary mechanism of beta-lactamase enzymes inhibited by clavulanic acid. Do not use this medication to treat bacterial infections caused by s.pneumonia resistant to penicillin.

    Convulsions can occur in patients with impaired renal function or high doses.

    Avoid using amoxicillin/ acid Clavulanic acid for patients suspected of having a mononulocytic hypertension because these patients are at risk of measles rash when using amoxicillin.

    Using alopurinol while being treated with amoxicillin may increase the risk of skin allergies.

    Take the drug that sometimes causes excessive growth of bacteria that are not sensitive to the drug.

    The appearance of a whole body erythema with pustules at the beginning of the treatment may be a manifestation of acute all -body pustules syndrome (AGEP).

    If these manifestations appear, the patient should stop the drug and contraindes to any preparation containing amoxicillin.

    Be cautious when used in combination with amoxicillin/ clavulanic acid for patients with impaired liver function.

    The side effects of the drug in the liver mainly occur in male patients, the elderly and the patient must be treated for a long time, rarely occurs in children. Typically, signs and symptoms usually occur during the process or after a short time of treatment, but in some cases, it may not be clear until several weeks after stopping treatment. These symptoms can often recover on their own. However, there are still cases of serious, even death, but very rare, mainly in patients with serious illness or use in combination with drugs that are at risk of affecting the liver.

    Colitis associated with antibiotics has been reported with almost all antibacterial agents including amoxicillin and can fluctuate in a level from mild to life -threatening. Therefore, it is necessary to diagnose this disease in patients with diarrhea during or after medication. If the fake colitis is caused by antibiotics, it is necessary to stop using amoxicillin/ clavulanic acid immediately and conduct appropriate treatments. The anti -peristalgic inhibitors in these cases.

    Periodically check the function of organs such as kidney and liver function, hematology index during long -term treatment. Prothrombin time has been reported in patients treated with mamoxicilin/ clavulanic acid, but it rarely occurs. The patient's condition should be monitored when used simultaneously with anticoagulants. It is possible to adjust the oral anticoagulant dose if necessary to maintain the concentration of anticoagulants as desired.

    Dosage for patients with renal impairment should be adjusted depending on the degree of renal failure (see the dose - Usage section).

    Very rare cases of urinary crystal observation in patients who reduce urine secretion, mainly in patients taking drugs in the form of injection.

    Patients should maintain sufficient amount of oral fluid in the urine to reduce the ability to cause crystal amoxicilinurin, especially when taking the drug in high doses.

    In patients with urine pipes, regular testing of urine tubes should be checked.

    During the treatment of amoxicillin, the glucose oxidase enzyme should be used when the glucose test is needed in the urine because of the non -enzyme methods that can give false positive results.

    Clavulanic acid in the drug can cause nonsense cohesion of IgG and albumin on the membrane of red blood cells, resulting in a false positive result of the Coombs solution.

    The drug can cause false positive testing Bio-Rad Laboratories Platelia Aspergillus EIA due to cross-reactions with polysaccharids and polyfuranose are not Aspergillus. Therefore, for patients who are taking amoxicilin and clavulanic acid, cautious if there is a positive result when testing by this method and should be further determined by other diagnostic methods.

    Information related to the excipients of the drug:

    Each package of oral powder Powder Lanam SC 200mg/28.5mg contains the corresponding 5 mg Aspartam (E951). After drinking, the Aspartam's excipient ingredient is hydrolyzed in the gastrointestinal tract. One of the hydrolysis products is phenylalanin, which can be harmful to patients with phenylketon (PKU).

    There is no clinical and non -clinical information evaluating the use of aspartam for children under 12 weeks of age.

    The excipients Manitol (E421) in the drug can cause mild laxative in patients.

    The effect of drugs on driving and operating machinery

    There are no studies on the effects of the drug on the ability to drive and operate machinery. However, some unwanted effects of the drug such as allergic reactions, dizziness, convulsions ... can reduce the ability to focus and react of the patient. Therefore, caution when using the drug for these objects. If the patient has the above unwanted effects, it is not advisable to drive or operate machinery.

    Using drugs for women during pregnancy and lactation

    Using drugs for pregnant women:

    Animal studies show that the drug is not directly or indirectly harmful to pregnancy, embryo/ fetal development, birth or development after birth.

    Data on the use of amoxicillin/ clavulanic acid in pregnant women also shows that it does not increase the risk of birth defects in children, however, these research data are still limited. A single study in premature women due to early rupture of amniotic fluid reported prophylactic treatment with amoxicillin/ clavulanic acid may increase the risk of necrotizing bowel infections in infants.

    Therefore, patients should avoid taking the drug during pregnancy, unless the doctor is prescribed.

    Use medicine for breastfeeding women:

    Amoxicilin and clavulanic acid are both breast milk (no information about the effect of clavulanic acid on breastfed babies). This can lead to diarrhea or fungal infection on mucous membranes in breastfed babies, thus stop breastfeeding to ensure safety for babies. Children's sensitivity to drugs should be considered.

    Amoxicilin/ Clavulanic Acid is only used during breastfeeding after being evaluated by a doctor between the benefits and potential risks.

    Drug interaction

    Interaction of drugs:

    Oral anticoagulant drugs:

    Oral anticoagulants and penicillin antibiotics have been widely used in reality without noting any interactions. However, in the literature, it refers to increasing international normalization index (INR) in patients using acenocoumarol or warfarin simultaneously with amoxicillin. If it is necessary to use simultaneously, it is advisable to carefully monitor prothrombin or INR time when starting or stopping using Lanam SC 200 mg/ 28.5 mg. Can adjust anticoagulant dose if needed.

    methotrexate:

    Penicillin antibiotics reduce methotrexate secretion, thus increasing the toxicity of methotrexate.

    Probenecid:

    Avoid simultaneously with Probenecid. Probenecid reduces amoxicillin secretion in the renal tubules thus increasing and prolonging the concentration of amoxicillin in the blood but does not affect clavulanic acid.

    mycophenolat mofetil:

    In patients who are taking Mycophenolat Mofetil, there has been reports on a 50% reduction in metabolites with the remaining mycophenolic acidic activity (MPA) after starting treatment with amoxicillin/ clavulanic acid combination. The change of this concentration may not accurately show changes in the overall MPa exposure level.

    Therefore, it is not necessary to adjust the dose of mycophenolat mofetil without clinical evidence of grafting dysfunction. However, clinical monitoring should be closely monitored during the use of the drug and a short time after stopping treatment with antibiotics.

    Oral contraceptive pills:

    Like antibiotics with broad effects, the drug can reduce the effectiveness of oral contraceptives.

    nifedipin:

    Increase amoxicillin absorption.

    Bacterial pliers:

    There may be antagonists between amoxicillin and bactericidal bacteria such as fusidic acid, chloramphenicol, tetracyclin.

    alopurinol:

    Patients with hyperuricemia when using alopurinol along with amoxicillin will increase the ability of amoxicillin.

    Diagnostic tests:

  • Glucose test in urine: During the treatment period with amoxicillin, should use the glucose oxidase enzyme method when needing glucose tests in urine because of the non -enzyme methods can give false positive results. The fake of the Coombs experiment. Therefore, for patients who are taking amoxicillin and clavulanic acid, cautious if there is a positive result when testing by this method and should be further determined by other diagnostic methods.
  • The cavalry of the drug:

    Due to the absence of studies on the correlation of the drug, not mixing this drug with other drugs.

    Storage

    Storage conditions: Not more than 30 degrees C, avoid moisture and light.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords